Egyptian International Pharmaceuticals
EIPICO is committed to its social responsibility. It has contributed to the "100 Million Healthy Lives" National Campaign aiming at elimination of hepatitis C virus (HCV) as a public health threat. EIPICO is ushering in a new era by enriching the Egyptian pharmaceutical sector through the localization of biological and biosimilar product manufacturing at its groundbreaking facility, EIPICO 3.
Basic Information
- Category: pharmacy
- Website: https://www.eipico.com.eg
Documented Facts
- Email: eipico@eipico.com.eg (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore pharmacy profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Egyptian International Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/egyptian-international-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/egyptian-international-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/egyptian-international-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (85/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
EIPICO is committed to its social responsibility. It has contributed to the "100 Million Healthy Lives" National Campaign aiming at elimination of hepatitis C virus (HCV) as a public health threat. EIPICO is ushering in a new era by enriching the Egyptian pharmaceutical sector through the localization of biological and biosimilar product manufacturing at its groundbreaking facility, EIPICO 3.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.